8 of 10 ECCO members trust Celltrion’s Remsima
At the 11th European Crohn’s and Colitis Organization(ECCO) held in Amsterdam, Netherlands from 16th to 19th of March, a survey was announced 8 of 10 ECCO members trust biosimilar antibodies like Remsima.
According to the survey, the credibility on biosimilars was only 39% in 2013, but was incre...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
